Clinical efficacy and safety of Flebogammadif®, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
Saved in:
| Title: | Clinical efficacy and safety of Flebogammadif®, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura. |
|---|---|
| Authors: | Julia, A.1 anjulia@vhebron.net, Kovaleva, L.2, Loria, S.3, Alberca, I.4, Hernandez, F.5, Sandoval, V.6, Sierra, J.7, Vidaller, A.8, Ayguasanosa, J.9, Carretero, M.9 |
| Source: | Transfusion Medicine. Oct2009, Vol. 19 Issue 5, p260-268. 9p. 4 Charts, 1 Graph. |
| Database: | Academic Search Ultimate |
| ISSN: | 09587578 |
|---|---|
| DOI: | 10.1111/j.1365-3148.2009.00945.x |
